Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.50B | 4.44B | 4.36B | 4.22B | 4.13B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.50B | 4.44B | 4.36B | 4.22B | 4.13B |
| Cost of Revenue | 1.51B | 1.46B | 1.42B | 1.36B | 1.32B |
| Gross Profit | 2.99B | 2.99B | 2.94B | 2.87B | 2.81B |
| SG&A Expenses | 1.68B | 1.65B | 1.62B | 1.57B | 1.53B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -12.89M | -20.96M | -21.18M | -21.52M | -21.30M |
| Total Operating Expenses | 3.34B | 3.24B | 3.17B | 3.05B | 2.97B |
| Operating Income | 1.16B | 1.20B | 1.19B | 1.17B | 1.16B |
| Income Before Tax | 595.85M | 619.56M | 532.05M | 937.20M | 910.86M |
| Income Tax Expenses | 120.04M | 189.29M | 206.86M | 331.29M | 373.49M |
| Earnings from Continuing Operations | 475.82 | 430.27 | 325.19 | 605.91 | 537.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 475.82M | 430.27M | 325.19M | 605.91M | 537.37M |
| EBIT | 1.16B | 1.20B | 1.19B | 1.17B | 1.16B |
| EBITDA | 1.38B | 1.40B | 1.39B | 1.36B | 1.34B |
| EPS Basic | 2.11 | 1.91 | 1.44 | 2.69 | 2.39 |
| Normalized Basic EPS | 3.05 | 3.18 | 2.97 | 2.81 | 2.75 |
| EPS Diluted | 2.11 | 1.91 | 1.44 | 2.69 | 2.38 |
| Normalized Diluted EPS | 3.05 | 3.18 | 2.97 | 2.81 | 2.75 |
| Average Basic Shares Outstanding | 900.80M | 900.80M | 901.00M | 901.20M | 901.20M |
| Average Diluted Shares Outstanding | 900.80M | 900.80M | 901.00M | 901.20M | 901.20M |
| Dividend Per Share | 3.55 | 3.60 | 3.60 | 3.52 | 3.52 |
| Payout Ratio | 169.73% | 187.69% | 247.17% | 132.66% | 133.79% |